lenvatinib,pembrolizumab
merck,eisai
['pembro', 'rcc,(-irccs),(-srcc),(-urcc)', 'lenva']
the #oncoalerttoptweet day 2 #asco23 tweet by faculty lenvatinib and pembrolizumab has activity in non-clear cell rcc. no randomised data makes patients characteristics relevant best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨